Last reviewed · How we verify
A New Approach to a Personalized Patient Blood Management Program in Total Hip Arthroplasty
The study evaluates the patient related risk and predictive factors concerning perioperative homologous blood cell transfusion (erythrocyte concentrate ) in THA patients in one EndoCert max-certified orthopedic hospital in Germany. A patient oriented preoperative decision-making algorithm (a personalised Patient Blood Management or pPBM App) will be developed as a new patient-safety blood-sparing strategy. The aim is to increase the patient safety by using the pPBM App and to reach a more efficient management of resources.
Details
| Lead sponsor | Krankenhaus der Barmherzigen Brüder Trier |
|---|---|
| Status | COMPLETED |
| Enrolment | 477 |
| Start date | 2015-08 |
| Completion | 2015-10 |
Conditions
- Postoperative Anemia
Primary outcomes
- Events and circumstances of Homologous Blood Transfusion (erythrocyte concentrate transfusion) — participants will be followed for the duration of hospital stay, an expected average of 10 days
Multivariate analysis of predictive variables like age, sex, BMI, hip and belly circumference, chronic kidney disease, chronic cardio-vascular disease, chronic inflammatory disease, diabetes mellitus, cancer, ASA Score, cemented, hybrid or not cemented prosthesis, surgery duration, medication and hemoglobin level before surgery
Countries
Germany